309 related articles for article (PubMed ID: 32213726)
1. Creatinine/(cystatin C × body weight) ratio is associated with skeletal muscle mass index.
Nishida K; Hashimoto Y; Kaji A; Okamura T; Sakai R; Kitagawa N; Osaka T; Hamaguchi M; Fukui M
Endocr J; 2020 Jul; 67(7):733-740. PubMed ID: 32213726
[TBL] [Abstract][Full Text] [Related]
2. Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes.
Osaka T; Hamaguchi M; Hashimoto Y; Ushigome E; Tanaka M; Yamazaki M; Fukui M
Diabetes Res Clin Pract; 2018 May; 139():52-58. PubMed ID: 29496508
[TBL] [Abstract][Full Text] [Related]
3. Estimation of Muscle Mass Using Creatinine/Cystatin C Ratio in Japanese Community-Dwelling Older People.
Kusunoki H; Tabara Y; Tsuji S; Wada Y; Tamaki K; Nagai K; Itoh M; Sano K; Amano M; Maeda H; Sugita H; Hasegawa Y; Kishimoto H; Shimomura S; Igase M; Shinmura K
J Am Med Dir Assoc; 2022 May; 23(5):902.e21-902.e31. PubMed ID: 34437868
[TBL] [Abstract][Full Text] [Related]
4. Serum creatinine to cystatin C ratio predicts skeletal muscle mass and strength in patients with non-dialysis chronic kidney disease.
Lin YL; Chen SY; Lai YH; Wang CH; Kuo CH; Liou HH; Hsu BG
Clin Nutr; 2020 Aug; 39(8):2435-2441. PubMed ID: 31732290
[TBL] [Abstract][Full Text] [Related]
5. A new index based on serum creatinine and cystatin C is useful for assessing sarcopenia in patients with advanced cancer.
Fu X; Tian Z; Wen S; Sun H; Thapa S; Xiong H; Liu H; Li L; Yu S
Nutrition; 2021 Feb; 82():111032. PubMed ID: 33172686
[TBL] [Abstract][Full Text] [Related]
6. Ratio of serum creatinine to cystatin C is related to leg strength in predialysis CKD patients.
Shiomi K; Saito C; Nagai K; Kosaki K; Kawamura T; Kaneko S; Kai H; Morito N; Usui J; Yanagi H; Yamagata K
Clin Exp Nephrol; 2021 Oct; 25(10):1079-1086. PubMed ID: 34342777
[TBL] [Abstract][Full Text] [Related]
7. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer.
Sun J; Yang H; Cai W; Zheng J; Shen N; Yang X; Pan B; Zhang W; Chen X; Shen X
BMC Gastroenterol; 2022 Jan; 22(1):26. PubMed ID: 35045814
[TBL] [Abstract][Full Text] [Related]
8. Creatinine-to-cystatin C ratio as a marker of skeletal muscle mass in older adults: J-SHIPP study.
Tabara Y; Kohara K; Okada Y; Ohyagi Y; Igase M
Clin Nutr; 2020 Jun; 39(6):1857-1862. PubMed ID: 31431305
[TBL] [Abstract][Full Text] [Related]
9. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease.
Hirai K; Tanaka A; Homma T; Goto Y; Akimoto K; Uno T; Yoshitaka U; Miyata Y; Inoue H; Ohta S; Suzuki S; Sagara H
Clin Nutr; 2021 Mar; 40(3):1274-1280. PubMed ID: 32863062
[TBL] [Abstract][Full Text] [Related]
10. Cre/CysC ratio may predict muscle composition and is associated with glucose disposal ability and macrovascular disease in patients with type 2 diabetes.
Yang Q; Zhang M; Sun P; Li Y; Xu H; Wang K; Shen H; Ban B; Liu F
BMJ Open Diabetes Res Care; 2021 Nov; 9(2):. PubMed ID: 34732398
[TBL] [Abstract][Full Text] [Related]
11. Serum creatinine-to-cystatin C ratio as an indicator of sarcopenia in hemodialysis patients.
Yajima T; Yajima K
Clin Nutr ESPEN; 2023 Aug; 56():200-206. PubMed ID: 37344074
[TBL] [Abstract][Full Text] [Related]
12. Cut-off points for weight and body mass index adjusted bioimpedance analysis measurements of muscle mass.
Bahat G; Tufan A; Kilic C; Öztürk S; Akpinar TS; Kose M; Erten N; Karan MA; Cruz-Jentoft AJ
Aging Clin Exp Res; 2019 Jul; 31(7):935-942. PubMed ID: 30267332
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of estimating appendicular muscle mass in heart failure using creatinine/cystatin C.
Sunayama T; Fujimoto Y; Matsue Y; Dotare T; Daichi M; Yatsu S; Ishiwata S; Nakamura Y; Akama Y; Tsujimura Y; Suda S; Kato T; Hiki M; Kasai T; Minamino T
Nutr Metab Cardiovasc Dis; 2023 Sep; 33(9):1733-1739. PubMed ID: 37407312
[TBL] [Abstract][Full Text] [Related]
14. Validation of the sarcopenia index to assess muscle mass in the critically ill: A novel application of kidney function markers.
Barreto EF; Poyant JO; Coville HH; Dierkhising RA; Kennedy CC; Gajic O; Nystrom EM; Takahashi N; Moynagh MR; Kashani KB
Clin Nutr; 2019 Jun; 38(3):1362-1367. PubMed ID: 29921462
[TBL] [Abstract][Full Text] [Related]
15. Relationships between cystatin C- and creatinine-based eGFR in Japanese rural community- dwelling older adults with sarcopenia.
Kusunoki H; Tsuji S; Kusukawa T; Wada Y; Tamaki K; Nagai K; Itoh M; Sano K; Amano M; Maeda H; Sugita H; Hasegawa Y; Kishimoto H; Shimomura S; Shinmura K
Clin Exp Nephrol; 2021 Mar; 25(3):231-239. PubMed ID: 33090338
[TBL] [Abstract][Full Text] [Related]
16. Estimating renal function in children: a new GFR-model based on serum cystatin C and body cell mass.
Andersen TB
Dan Med J; 2012 Jul; 59(7):B4486. PubMed ID: 22759853
[TBL] [Abstract][Full Text] [Related]
17. Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis.
Fujita K; Ohkubo H; Nakano A; Takeda N; Fukumitsu K; Fukuda S; Kanemitsu Y; Uemura T; Tajiri T; Maeno K; Ito Y; Oguri T; Ozawa Y; Murase T; Niimi A
BMC Pulm Med; 2022 May; 22(1):203. PubMed ID: 35606777
[TBL] [Abstract][Full Text] [Related]
18. Serum creatinine to cystatin C ratio is associated with major adverse cardiovascular events in patients with obstructive coronary artery disease.
Lu YW; Tsai YL; Chou RH; Kuo CS; Chang CC; Huang PH; Lin SJ
Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1509-1515. PubMed ID: 33810966
[TBL] [Abstract][Full Text] [Related]
19. Association of Creatinine-to-Cystatin C Ratio with Myosteatosis and Physical Performance in Older Adults: The Japan Shimanami Health Promoting Program.
Tabara Y; Okada Y; Ochi M; Ohyagi Y; Igase M
J Am Med Dir Assoc; 2021 Nov; 22(11):2366-2372.e3. PubMed ID: 33915077
[TBL] [Abstract][Full Text] [Related]
20. Novel equations incorporating the sarcopenia index based on serum creatinine and cystatin C to predict appendicular skeletal muscle mass in patients with nondialysis CKD.
Hsu BG; Wang CH; Lai YH; Kuo CH; Lin YL
Clin Nutr; 2024 Mar; 43(3):765-772. PubMed ID: 38335801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
